| Cat. No. |
Product Name |
Information |
| PC-38745 |
CK156
STK17A (DRAK1) inhibitor
|
CK156 is a potent, highly selective serine/threonine kinase 17A (DRAK1) inhibitor with Kd of 21 nM, cellular IC50 of 182 nM. |
| PC-38222 |
SGC-STK17B-1
STK17B (DRAK2) inhibitor
|
SGC-STK17B-1 is a potent, selective, ATP-competitive inhibitor of death-associated protein kinase family member STK17B (DRAK2) with IC50 of 34 nM, >100-fold selectivity over STK17A. |
| PC-38221 |
Dual DRAK1 and DRAK2 inhibitor 1
DRAK2/1 inhibitor
|
Dual DRAK1 and DRAK2 inhibitor 1 is a potent, dual DRAK2/1 inhibitor Kd value of 9/5 nM, respectively. |
| PC-35494 |
HS148
DAPK3 inhibitor
|
HS148 (DAPK3 inhibitor HS148) is a selective DAPK3 inhibitor with Ki of 119 nM, >10-fold selectivity over Pim kinases.. |
| PC-35493 |
HS94
DAPK3 inhibitor
|
HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases. |
| PC-35492 |
HS56
Pim/DAPK3 inhibitor
|
HS56 (Pim-DAPK3 inhibitor HS56) is a potent, dual Pim/DAPK3 inhibitor with Ki of 72 nM (Pim-3) and 315 nM (DAPK3), shows micromolar potency toward Pim-1 and Pim-2 (Ki=1.5 and 17 uM). |
| PC-62870 |
HS-38
DAPK1/3 inhibitor
|
HS-38 is a potent and selective DAPK1 and DAPK3 (ZIPK) inhibitor with IC50 of 200 nM for DAPK1 and Kd of 280 nM for ZIPK. |
| PC-62719 |
DRAK2-IN-16
DRAK2 inhibitor
|
DRAK2-IN-116 is a potent, selective DRAK2 inhibitor with IC50 of 3 nM, shows weak inhibition for DRAK1 (IC50=51 nM) and no significant activity against DAPK1/2/3 (IC50>1 uM).. |
| PC-23345 |
BLU7482
STK17B inhibitor
|
BLU7482 is a potent, selective and orally bioavailable inhibitor of serine/threonine kinase 17B (STK17B, DRAK2) with IC50 of 1.0 nM, 45-fold selective over STK17A. |
| PC-22727 |
TC-DAPK6
DAPK1/3 inhibitor
|
TC-DAPK6 is a potent, specific, ATP-competitiveinhibitor of death associated protein kinase (DAPK) with IC50 of 69 and 225 nM for DAPK1 and ZIPK (DAPK3) respectively. |
| PC-22555 |
STK17A/B inhibitor 9
STK17A/B inhibitor
|
STK17A/B inhibitor 9 is a potent and selective, orally active STK17A/B inhibitor with IC50 of 23 nM (STK17A/DRAK1). |
